How often does ADC Therapeutics move more than the options market prices?

0 of the last 7 reports moved at least as far as the implied move.

ADCTNYSEPharmaceutical Preparations

ADC Therapeutics SA (ADCT) earnings date, market-implied expected move, and options open interest by expiry

1.56

Pre-market17:01 ETdelayed

Open1.55Volume865,811Mkt cap$197.9M

Day1.54 – 1.6418%52-wk0.78 – 4.9819%

ADCT

ADC Therapeutics SA

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

Next report

Last report

−8.60%

shaded = implied · ▲▼ = realized

Oct 13 '26 · confirmed

Implied vs realized

Largest filed tie

39.00%

of ADCT revenue · AmerisourceBergen

customerADCT 10-K

Supply chain

Largest filed tie

13F top-10 QoQ

+7.21%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

113 managers

Top fund weight

0.00%

ADCT weight · IWM

N-PORTJun 30 '26

2 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

ADC Therapeutics (ADCT) reports on Nov 9 after close (confirmed date).

Implied vs realized

8 reports

0 of 7≥ implied

avg implied: ±42.4%
avg realized: ±12.2%

May 14 '25May 14 '25confirmed±44.4%▲+37.12%×0.84

Aug 12 '25Aug 12 '25confirmed±25.3%▲+9.70%×0.38

Q3 FY25Nov 10 '25confirmed±34.2%▲+4.21%×0.12

Jan 8 '26Jan 8 '26confirmed±40.5%▲+2.52%×0.06

Q1 FY26Mar 10 '26confirmed±38.8%▲+13.48%×0.35

May 4 '26May 4 '26confirmed±23.0%▼−3.92%×0.17

Q2 FY26Aug 13 '26confirmed±90.3%▼−14.63%×0.16

Oct 13 '26Oct 13 '26confirmed—▼−8.60%—

quarterimplied−95%0+95%realized×

Oct '26—▼−8.60%—

Q2 FY26±90.3%−14.63%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 3 close

0.01OI · 4 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

20%Nov 2016d266+2%

0—Dec 1844d0.001540%0.00

10%Jan 1572d0.002,0570%0.00

0—Apr 16163d0.002270%0.00

ExpiryPutsCallsP/C

Nov 2016d20%266+2%0.01

Dec 1844d0—1540%0.00

Jan 1572d10%2,0570%0.00

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−86.06%as filednet margin · revenue −7.69% QoQ · +2.17% YoY

Revenue$19M−7.69%

Gross profit$17M87.80%−1.96%

Operating income−$25M−132.03%−0.67%

Pre-tax income−$17M+49.75%

Net income−$17M−86.06%+49.75%

Cost of revenue$2M−35.02%

Operating expenses$42M−0.40%

Tax$0—

Other income$9M+214.58%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 17:00 ET

Intraday

Event sensitivity

FOMC ×1.46· ±6.6% vs ±4.5% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±6.6%10 of 24×1.46

NFPjobs report±5.1%5 of 10×1.13

PPIproducer prices±4.2%4 of 10×0.92

PCEpersonal income & outlays±3.8%9 of 19×0.85

CPROFcorporate profits±2.7%6 of 12×0.59

GDPgross domestic product±2.6%9 of 19×0.57

CPIconsumer prices±2.3%3 of 10×0.51

Bar = avg |move| to ±7% · tick = ±4.5% avg day · ×base = |move| ÷ ±4.5% · min 6 releases

Earnings history

EPS -0.11 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 13 '26 · confirmed	-0.11	—
Q1 FY26	Mar 10 '26 · confirmed	-0.21	—
Q3 FY25	Nov 10 '25 · confirmed	-0.30	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod